BRUSSELS (Reuters) - U.S. regulators have cleared UCB’s Cimzia for the treatments of adult patients with active psoriatic arthritis, the Belgian group said on Monday. Psoriatic arthritis is an inflammatory disease that affects joints and tendons, and usually occurs in combination with…
Source: FDA clears UCB’s Cimzia for psoriatic arthritis treatment
Sunday, September 29, 2013
FDA clears UCB's Cimzia for psoriatic arthritis treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment